
Align Technology Inc
ALGNAlign Technology Inc (ALGN) is a medical device company known for its clear aligner orthodontic products, primarily Invisalign. Founded in 1997, the company develops and markets innovative orthodontic solutions that improve teeth alignment and dental aesthetics. Its technology integrates digital imaging, software, and manufacturing processes, enabling personalized treatment plans. Align Technology also offers digital scanning and imaging systems to dental professionals worldwide.
Company News
While the S&P 500 reaches record highs driven primarily by large technology companies trading at elevated valuations, several S&P 500 stocks have lagged behind and are trading at significant discounts of 27-61% below fair value estimates. These undervalued stocks, including gold producers and healthcare companies, present potential catch-up oppor...
Activist investor Elliott Investment Management has taken a large stake in Align Technology (ALGN), positioning itself to push for strategic changes to boost shareholder value. The move comes as Align struggles with weakened demand post-pandemic, though Q4 2025 showed record Invisalign volumes. Barclays upgraded the stock to Overweight with a $20...
The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow f...
The global invisible orthodontics market is projected to grow from USD 9.91 billion in 2025 to USD 96.27 billion by 2034, expanding at a CAGR of 28.54%. Clear aligners dominate the product segment, with North America leading regionally and Asia-Pacific showing significant growth potential. Adults currently represent the largest age segment, while...
Align Technology reported record Invisalign case submissions in Q4 with 87.7 thousand doctors submitting cases. Revenue beat expectations at $1.048 billion (+5.3% YoY) and adjusted EPS of $3.29 surpassed consensus of $2.97. The company projects 3-4% revenue growth for fiscal 2026 with improving margins, sending shares up 10.43% in premarket tradi...









